“Being involved in a clinical trial saved my life” – Tony’s story 26 Jun 2024 Tony McHale, a screenwriter, was invited to take part in the IMPACT study in 2012, an international clinical trial offering regular screening for men at increased risk of prostate cancer. Around 18 months later, he was diagnosed with the disease at the age of 61. After undergoing intense radiotherapy treatment, he has remained cancer-free ever since. Find out more Show/Hide
Racing for research – Lucy and Suzie’s stories of running the London Marathon for the ICR 01 May 2024 Completing a marathon is no easy feat – but this year two of our #TeamICR runners who took on the London Marathon had been diagnosed and treated for breast cancer in the past five years. They tell us what cancer research means to them. Find out more Show/Hide
A new era for treating high-risk neuroblastoma – research advances to look out for in 2024 24 Apr 2024 It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to further advance this research. We look at some of the latest advances and how they could change the outlook for children with neuroblastoma. Find out more Show/Hide
Switching lab coats for formal wear – ICR scientists have “an amazing day” at Buckingham Palace 28 Mar 2024
Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023
ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021